Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2013 1
2014 1
2016 2
2017 1
2018 2
2019 3
2020 3
2021 3
2023 2
2024 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

15 results

Results by year

Filters applied: . Clear all
Page 1
Continuous and Daily Oral Immunotherapy for Peanut Allergy: Results from a 2-Year Open-Label Follow-On Study.
Vickery BP, Vereda A, Nilsson C, du Toit G, Shreffler WG, Burks AW, Jones SM, Fernández-Rivas M, Blümchen K, O'B Hourihane J, Beyer K, Anagnostou A, Assa'ad AH, Ben-Shoshan M, Bird JA, Carr TF, Carr WW, Casale TB, Chong HJ, Ciaccio CE, Dorsey MJ, Fineman SM, Fritz SB, Greiner AN, Greos LS, Hampel FC Jr, Ibáñez MD, Jeong DK, Johnston DT, Kachru R, Kim EH, Lanser BJ, Leonard SA, Maier MC, Mansfield LE, Muraro A, Ohayon JA, Oude Elberink JNG, Petroni DH, Pongracic JA, Portnoy JM, Rachid R, Rupp NT, Sanders GM, Sharma HP, Sharma V, Sher ER, Sher L, Sindher SB, Siri D, Spergel JM, Sprikkelman AB, Sussman GL, Tsoumani M, Varshney P, Vitalpur G, Wang J, Yang WH, Zubeldia JM, Smith A, Ryan R, Adelman DC. Vickery BP, et al. Among authors: vitalpur g. J Allergy Clin Immunol Pract. 2021 May;9(5):1879-1889.e13. doi: 10.1016/j.jaip.2020.12.029. Epub 2020 Dec 24. J Allergy Clin Immunol Pract. 2021. PMID: 33359589 Free article. Clinical Trial.
Preventing asthma in high risk kids (PARK) with omalizumab: Design, rationale, methods, lessons learned and adaptation.
Phipatanakul W, Mauger DT, Guilbert TW, Bacharier LB, Durrani S, Jackson DJ, Martinez FD, Fitzpatrick AM, Cunningham A, Kunselman S, Wheatley LM, Bauer C, Davis CM, Geng B, Kloepfer KM, Lapin C, Liu AH, Pongracic JA, Teach SJ, Chmiel J, Gaffin JM, Greenhawt M, Gupta MR, Lai PS, Lemanske RF, Morgan WJ, Sheehan WJ, Stokes J, Thorne PS, Oettgen HC, Israel E; PARK Study Team. Phipatanakul W, et al. Contemp Clin Trials. 2021 Jan;100:106228. doi: 10.1016/j.cct.2020.106228. Epub 2020 Nov 24. Contemp Clin Trials. 2021. PMID: 33242697 Free PMC article. Clinical Trial.
Management of food allergy in the school setting.
Huddleston CM, Kloepfer KM, Jin JJ, Vitalpur GV. Huddleston CM, et al. Among authors: vitalpur gv. J Food Allergy. 2020 Sep 1;2(1):104-107. doi: 10.2500/jfa.2020.2.200023. eCollection 2020 Sep. J Food Allergy. 2020. PMID: 39022140 Free PMC article.
Multicenter prevalence of anaphylaxis in clinic-based oral food challenges.
Akuete K, Guffey D, Israelsen RB, Broyles JM, Higgins LJ, Green TD, Naimi DR, MacGinnitie AJ, Vitalpur G, Minard CG, Davis CM. Akuete K, et al. Among authors: vitalpur g. Ann Allergy Asthma Immunol. 2017 Oct;119(4):339-348.e1. doi: 10.1016/j.anai.2017.07.028. Epub 2017 Sep 7. Ann Allergy Asthma Immunol. 2017. PMID: 28890356 Free article.
Designer covalent heterobivalent inhibitors prevent IgE-dependent responses to peanut allergen.
Deak PE, Kim B, Abdul Qayum A, Shin J, Vitalpur G, Kloepfer KM, Turner MJ, Smith N, Shreffler WG, Kiziltepe T, Kaplan MH, Bilgicer B. Deak PE, et al. Among authors: vitalpur g. Proc Natl Acad Sci U S A. 2019 Apr 30;116(18):8966-8974. doi: 10.1073/pnas.1820417116. Epub 2019 Apr 8. Proc Natl Acad Sci U S A. 2019. PMID: 30962381 Free PMC article.
15 results